“I watched person after person around me go on GLP-1 medications. Every one of them hit the same wall.”

I didn’t plan to start a supplement company. I’m an engineer from Bucharest, based in London. I’ve spent most of my career in technology — and, for a stretch, running a small biotech lab.

What made SQ[1] happen was what I started to notice around me. Over the course of a year, person after person in my life went on GLP-1 medications. Friends. People I loved. Then another. Then another.

They all lost weight. They all ran into the same wall. Hair. Energy. The face in the mirror. Sleep. The medication was doing exactly what the prescription said it would do — and underneath, the body was being quietly unbuilt in ways nobody was warning them about.

So I read. The STEP-1 trial data. The 2025 clinical advisory. The muscle-mass papers. What I learned: between twenty-five and forty percent of what a GLP-1 user loses is not fat. It is muscle. Bone. Skin. Connective tissue. The scale says victory. The body is paying a quiet cost nobody was talking about.

From the years in the lab I knew what research-led formulation looked like — real therapeutic doses, not sprinkles for marketing. What didn’t exist was anyone applying that standard to the half of the GLP-1 story nobody was writing: nutrition.

SQ[1] is the other half of that story. Ten products. Numbered. Each one mapped to a specific thing rapid weight loss takes — protein to protect lean mass, collagen for the face, electrolytes for the headaches, fiber for the part nobody talks about.

Not anti-pharma. Not supplement-cult. A protocol.

It’s what I wish the people around me had been handed the day their medications started. If you are on a GLP-1, or you love someone who is, this is built for you.